Research library
Oral GLP-1 treatments, explained
12 guides, organized by the question you are trying to answer.
Research Guides
Semaglutide tablets, drops and lozenges: ask for formulation-specific evidence
A guide to separating approved oral products from compounded preparations and unsupported evidence transfers.
Food, water and other tablets: build the routine around the exact product
Why oral semaglutide and Foundayo need separate administration checklists, with practical questions for a pharmacist.
Medication review before an oral GLP-1 switch
Prepare the product history, interaction questions and written handoff needed before changing an oral GLP-1 medicine.
Oral semaglutide and physical function: look beyond the scale
Understand OASIS 4’s patient-reported physical-function endpoint and how to discuss meaningful daily-life goals.
Why oral GLP-1 trial percentages do not form a ranking
Read OASIS, PIONEER and ATTAIN results by population, dose, comparator and analysis before comparing products.
Why oral semaglutide depends on its formulation
Understand SNAC, exposure and why a tablet study cannot validate an unrelated oral preparation.
Oral semaglutide and liver impairment: drug exposure is not liver-treatment efficacy
A pharmacokinetic study answers a different question from a MASH trial or a long-term safety study.
Oral GLP-1 medicines are not all the same kind of molecule
Compare peptide semaglutide tablets and small-molecule orforglipron by product, indication and daily routine.
Oral semaglutide alongside insulin: an add-on study is not a replacement plan
Understand PIONEER 8’s combination-treatment question and the clinical handoff needed before changing an insulin-based plan.
Oral semaglutide with reduced kidney function: what PIONEER 5 tested
Distinguish glucose-control evidence in moderate renal impairment from a long-term kidney-outcome claim.
Tablet versus injection: what the liraglutide comparison actually established
Read PIONEER 4’s noninferiority result without turning one direct comparison into a verdict on all oral and injectable GLP-1 medicines.
Oral semaglutide versus sitagliptin: make the comparison match the goal
PIONEER 3 provides a direct tablet comparison in a defined diabetes population, with separate glucose, weight and tolerability questions.
